Role of the Quantitative Imaging Biomarker Alliance in optimizing CT for the evaluation of lung cancer screen-detected nodules.

[1]  F. Rybicki,et al.  CAD-RADS™: Coronary Artery Disease - Reporting and Data System: An Expert Consensus Document of the Society of Cardiovascular Computed Tomography (SCCT), the American College of Radiology (ACR) and the North American Society for Cardiovascular Imaging (NASCI). Endorsed by the American College of Car , 2016, Journal of the American College of Radiology : JACR.

[2]  M. R. Armstrong,et al.  ACR CT Accreditation Program and the Lung Cancer Screening Program Designation. , 2016, Journal of the American College of Radiology : JACR.

[3]  N. Obuchowski,et al.  Introduction to metrology series , 2015, Statistical methods in medical research.

[4]  H. Barnhart,et al.  The emerging science of quantitative imaging biomarkers terminology and definitions for scientific studies and regulatory submissions , 2015, Statistical methods in medical research.

[5]  Kyle J Myers,et al.  Quantitative imaging biomarkers: A review of statistical methods for computer algorithm comparisons , 2014, Statistical methods in medical research.

[6]  Huiman X Barnhart,et al.  Statistical issues in the comparison of quantitative imaging biomarker algorithms using pulmonary nodule volume as an example , 2015, Statistical methods in medical research.

[7]  Mithat Gönen,et al.  Quantitative imaging biomarkers: A review of statistical methods for technical performance assessment , 2015, Statistical methods in medical research.

[8]  Fenghai Duan,et al.  Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination. , 2014, Journal of the National Cancer Institute.

[9]  J. Mulshine,et al.  Issues with implementing a high‐quality lung cancer screening program , 2014, CA: a cancer journal for clinicians.

[10]  Michael F. McNitt-Gray,et al.  ACR–STR Practice Parameter for the Performance and Reporting of Lung Cancer Screening Thoracic Computed Tomography (CT): 2014 (Resolution 4)* , 2014, Journal of thoracic imaging.

[11]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[12]  Ella Kazerooni,et al.  National lung screening trial: variability in nodule detection rates in chest CT studies. , 2013, Radiology.

[13]  C. Henschke,et al.  Computed Tomography Screening for Lung Cancer , 2013, Annals of Internal Medicine.

[14]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[15]  David F Yankelevitz,et al.  Definition of a Positive Test Result in Computed Tomography Screening for Lung Cancer , 2013, Annals of Internal Medicine.

[16]  Matthew B Schabath,et al.  Lung cancer screening. , 2003, Journal of the National Comprehensive Cancer Network : JNCCN.

[17]  Paul F. Pinsky,et al.  Evaluation of reader variability in the interpretation of follow-up CT scans at lung cancer screening. , 2011, Radiology.

[18]  D. Sullivan,et al.  A collaborative enterprise for multi-stakeholder participation in the advancement of quantitative imaging. , 2011, Radiology.

[19]  Nicholas Petrick,et al.  Volumetric CT in lung cancer: an example for the qualification of imaging as a biomarker. , 2010, Academic radiology.

[20]  Andrew J Buckler,et al.  The use of volumetric CT as an imaging biomarker in lung cancer. , 2010, Academic radiology.

[21]  Volume CT for diagnosis of nodules found in lung-cancer screening. , 2009, The New England journal of medicine.

[22]  Kavita Garg,et al.  Lung cancer: interobserver agreement on interpretation of pulmonary findings at low-dose CT screening. , 2008, Radiology.

[23]  C. Henschke,et al.  The role of CT screening for lung cancer. , 2007, Thoracic surgery clinics.

[24]  I. Kron.  The American Association for Thoracic Surgery , 2005 .

[25]  Ella A. Kazerooni,et al.  Interobserver and Intraobserver Variability in the Assessment of Pulmonary Nodule Size on CT Using Film and Computer Display Methods1 , 2005 .

[26]  Benoit Desjardins,et al.  Interobserver and intraobserver variability in the assessment of pulmonary nodule size on CT using film and computer display methods. , 2005, Academic radiology.

[27]  D. DeMets,et al.  Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework , 2001, Clinical pharmacology and therapeutics.

[28]  G. Bepler,et al.  Screening for lung cancer. , 2000, The New England journal of medicine.

[29]  Binsheng Zhao,et al.  Small pulmonary nodules: volumetrically determined growth rates based on CT evaluation. , 2000, Radiology.